X-49075271-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001029896.2(WDR45):c.838G>A(p.Val280Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00224 in 1,209,412 control chromosomes in the GnomAD database, including 51 homozygotes. There are 829 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0067 ( 18 hom., 288 hem., cov: 24)
Exomes 𝑓: 0.0018 ( 33 hom. 541 hem. )
Consequence
WDR45
NM_001029896.2 missense
NM_001029896.2 missense
Scores
2
3
11
Clinical Significance
Conservation
PhyloP100: 7.26
Genes affected
WDR45 (HGNC:28912): (WD repeat domain 45) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene has a pseudogene at chromosome 4q31.3. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity and full-length nature of some variants have not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.005992919).
BP6
Variant X-49075271-C-T is Benign according to our data. Variant chrX-49075271-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 282969.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-49075271-C-T is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0586 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR45 | NM_001029896.2 | c.838G>A | p.Val280Met | missense_variant | 10/11 | ENST00000376372.9 | NP_001025067.1 | |
WDR45 | NM_007075.4 | c.841G>A | p.Val281Met | missense_variant | 11/12 | NP_009006.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR45 | ENST00000376372.9 | c.838G>A | p.Val280Met | missense_variant | 10/11 | 1 | NM_001029896.2 | ENSP00000365551.3 | ||
ENSG00000288053 | ENST00000376358.4 | c.521+93G>A | intron_variant | 2 | ENSP00000365536.3 |
Frequencies
GnomAD3 genomes AF: 0.00672 AC: 755AN: 112294Hom.: 18 Cov.: 24 AF XY: 0.00829 AC XY: 286AN XY: 34496
GnomAD3 genomes
AF:
AC:
755
AN:
112294
Hom.:
Cov.:
24
AF XY:
AC XY:
286
AN XY:
34496
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00670 AC: 1209AN: 180428Hom.: 19 AF XY: 0.00491 AC XY: 322AN XY: 65530
GnomAD3 exomes
AF:
AC:
1209
AN:
180428
Hom.:
AF XY:
AC XY:
322
AN XY:
65530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00178 AC: 1957AN: 1097065Hom.: 33 Cov.: 32 AF XY: 0.00149 AC XY: 541AN XY: 362495
GnomAD4 exome
AF:
AC:
1957
AN:
1097065
Hom.:
Cov.:
32
AF XY:
AC XY:
541
AN XY:
362495
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00675 AC: 758AN: 112347Hom.: 18 Cov.: 24 AF XY: 0.00833 AC XY: 288AN XY: 34559
GnomAD4 genome
AF:
AC:
758
AN:
112347
Hom.:
Cov.:
24
AF XY:
AC XY:
288
AN XY:
34559
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
424
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 06, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 03, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 17, 2024 | - - |
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Neurodegeneration with brain iron accumulation 5;C3808786:Oculocutaneous albinism type 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 30, 2021 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Neurodegeneration with brain iron accumulation 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;.;T;.;.;.;.;T;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;D;D;.;D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N;.;.;.;.;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;.;.;.;N;N;N;N;.;.;.
REVEL
Uncertain
Sift
Benign
T;.;.;.;.;T;T;T;T;.;.;.
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;.;.
Polyphen
B;B;.;.;.;B;B;B;B;.;.;.
Vest4
MVP
MPC
0.62
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at